p190-B, a Rho-GTPase-activating protein, is differentially expressed in terminal end buds and breast cancer

Citation
G. Chakravarty et al., p190-B, a Rho-GTPase-activating protein, is differentially expressed in terminal end buds and breast cancer, CELL GROWTH, 11(7), 2000, pp. 343-354
Citations number
36
Categorie Soggetti
Cell & Developmental Biology
Journal title
CELL GROWTH & DIFFERENTIATION
ISSN journal
10449523 → ACNP
Volume
11
Issue
7
Year of publication
2000
Pages
343 - 354
Database
ISI
SICI code
1044-9523(200007)11:7<343:PARPID>2.0.ZU;2-0
Abstract
Microdissection and differential display PCR were used to identify genes pr eferentially expressed in the highly proliferative terminal end buds (TEBs) in the mammary gland of 45-day-old virgin rats. One clone exhibited 87% ho mology to the human p190-B gene encoding a novel Rho-Gap, Using in situ hyb ridization, p190-B was detected in both the TEBs and the terminal ducts, wi th the highest expression observed in the outer layer of TEBs, During norma l mammary gland development, p190-B mRNA expression was highest in the virg in mammary gland and decreased during late pregnancy and lactation. Interes tingly, increased levels of p190-B mRNA relative to the normal mammary glan d were seen in a subset of murine mammary tumors that appeared to be less w ell differentiated and potentially more aggressive. Transient transfection of a p190-B expression construct into MCF-10A human mammary epithelial cell s resulted in disruption of the actin cytoskeleton, which suggests a role f or p190-B in regulating the signaling pathways that influence cell migratio n and invasion. These results suggest that p190-B may be required for virgi n mammary gland development, and its aberrant expression may occur in breas t cancer.